Matthias Egger
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- COVID-19 Clinical Research Studies
- Epidemiology top 10%
- Fungal Infections and Studies
- Infective Endocarditis Diagnosis and Management
- Liver Disease Diagnosis and Treatment
Papers in
-
- Antifungal resistance and susceptibility 28
- COVID-19 Clinical Research Studies 3
-
- Fungal Infections and Studies 4
- Infective Endocarditis Diagnosis and Management 1
- Liver Disease Diagnosis and Treatment 1
- Co-authors
- Martin Hoenigl (25 shared papers)Jeffrey D. Jenks (10 shared papers)George R. Thompson (8 shared papers)Juergen Prattes (12 shared papers)Robert Krause (8 shared papers)Rosanne Sprute (4 shared papers)Amir A. Arastehfar (3 shared papers)Oliver A. Cornely (5 shared papers)
- Journals
- Mycopathologia (4 papers)Journal of Clinical Microbiology (3 papers)Mycoses (3 papers)EClinicalMedicine (2 papers)Clinical Microbiology Reviews (2 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Matthias Egger
39 papers receiving 1.6k citations
Matthias Egger's Hit Papers
Peers
Comparison fields: 5 of 83
- Infectious Diseases 1.2k
- Epidemiology 267
- Applied Microbiology and Biotechnology 14
- Microbiology 5
- Immunology and Allergy 20
Countries citing papers authored by Matthias Egger
This map shows the geographic impact of Matthias Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Egger more than expected).
Fields of papers citing papers by Matthias Egger
This network shows the impact of papers produced by Matthias Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Egger. The network helps show where Matthias Egger may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Egger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin Hit paper breakdown → | 2021 | 342 |
| 2 | Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap Hit paper breakdown → | 2023 | 181 |
| 3 | Impact of climate change and natural disasters on fungal infections Hit paper breakdown → | 2024 | 135 |
| 4 | Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study Hit paper breakdown → | 2023 | 106 |
| 5 | Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease Hit paper breakdown → | 2024 | 95 |
| 6 | 2023 | 66 | |
| 7 | 2022 | 58 | |
| 8 | New treatment options for critically important WHO fungal priority pathogens Hit paper breakdown → | 2024 | 56 |
| 9 | 2020 | 42 | |
| 10 | 2022 | 40 | |
| 11 | 2021 | 39 | |
| 12 | 2023 | 39 | |
| 13 | 2023 | 38 | |
| 14 | 2023 | 38 | |
| 15 | 2022 | 37 | |
| 16 | 2021 | 36 | |
| 17 | 2023 | 35 | |
| 18 | 2017 | 25 | |
| 19 | 2023 | 23 | |
| 20 | 2023 | 23 |
About Matthias Egger
Matthias Egger is a scholar working on Infectious Diseases, Epidemiology, Oncology, Immunology and Allergy and Hepatology, having authored 39 papers that have together received 1.7k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (28 papers), Fungal Infections and Studies (4 papers), COVID-19 Clinical Research Studies (3 papers), COVID-19 and healthcare impacts (2 papers), Liver Disease and Transplantation (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Alcohol Consumption and Health Effects (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (1.2k citations), Epidemiology (267 citations), Applied Microbiology and Biotechnology (14 citations), Microbiology (5 citations) and Immunology and Allergy (20 citations). Matthias Egger has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Martin Hoenigl, Jeffrey D. Jenks, George R. Thompson, Juergen Prattes, Robert Krause, Rosanne Sprute, Amir A. Arastehfar, Oliver A. Cornely, Cornelia Lass‐Flörl and Nathan P. Wiederhold. Their work appears in journals such as Mycopathologia, Journal of Clinical Microbiology, Mycoses, EClinicalMedicine and Clinical Microbiology Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.